Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Mar 16;17(3):e80673.
doi: 10.7759/cureus.80673. eCollection 2025 Mar.

Late-Onset Thyroid Hormone Resistance Following Total Thyroidectomy for Papillary Thyroid Cancer

Affiliations
Case Reports

Late-Onset Thyroid Hormone Resistance Following Total Thyroidectomy for Papillary Thyroid Cancer

Ambika Kapil et al. Cureus. .

Abstract

Thyroid hormone resistance (RTH) is a rare disorder characterized by impaired cellular responsiveness to thyroid hormones, leading to discordant thyroid function tests and varied clinical manifestations. We present the case of a 43-year-old Cuban-American female patient who presented with dizziness, vertigo, repeated falls, and a severe headache following a minor fall. Additional symptoms included nausea, vomiting, photophobia, cold intolerance, generalized body aches, and fatigue. Her medical history was significant for total thyroidectomy for papillary thyroid cancer, multiple sclerosis (MS), pituitary macroadenoma, Cushing's disease, and polycystic ovary syndrome (PCOS). Post-thyroidectomy, she remained on high-dose levothyroxine (400-750 mcg daily). However, laboratory tests showed persistently elevated thyroid-stimulating hormone (TSH) levels, hence raising suspicion for RTH. This case highlights the challenges of diagnosing and managing RTH, a rare endocrine disorder often resulting from mutations in the thyroid hormone receptor-beta (THB) gene. RTH is characterized by inappropriately normal or elevated TSH despite high thyroid hormone levels, reflecting tissue-level resistance. This case underscores the complexities of identifying RTH in the setting of multiple comorbidities and a history of thyroidectomy. It also emphasizes the need for clinician awareness of atypical presentations of RTH, particularly in patients with extensive endocrine and systemic histories.

Keywords: delayed presentation; genetic mutations in thyroid hormone signaling; hyperthyroxinemia with normal tsh; thyroid cancer treatment outcomes; thyroid hormone resistance (rth).

PubMed Disclaimer

Conflict of interest statement

Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Figures

Figure 1
Figure 1. Baseline electrocardiogram (EKG) showing sinus bradycardia with a heart rate of 41 bpm (red box)
Figure 2
Figure 2. (A-C) Brain CT without intravenous contrast agents. No CT evidence of acute intracranial hemorrhage, midline shift, or mass effect
CT: computed tomography
Figure 3
Figure 3. Abdominal CT without contrast. Shows small anterior pelvic soft tissue contusion (red circle), but no other intra-abdominal/adrenal or intrapelvic abnormalities
CT: computed tomography
Figure 4
Figure 4. Transverse (A) and anterior-posterior (B) CT chest without intravenous contrast showing no acute cardiopulmonary disease. No definite focal lesions in the thyroid gland region (red arrow)
CT: computed tomography
Figure 5
Figure 5. Echocardiogram during hospital admission showed moderate concentric left ventricular hypertrophy and preserved left ventricular ejection fraction (LVEF) (red box)
Figure 6
Figure 6. Abdominal ultrasound showed mild hepatomegaly and increased liver echogenicity, which was suspected to represent hepatic steatosis (yellow outline)

Similar articles

References

    1. Coexistence of resistance to thyroid hormone and papillary thyroid carcinoma. Igata M, Tsuruzoe K, Kawashima J, et al. Endocrinol Diabetes Metab Case Rep. 2016;2016:160003. - PMC - PubMed
    1. The clinical characteristics and gene mutations associated with thyroid hormone resistance syndrome coexisting with pituitary tumors. Zhao J, Xu L, Li C, Wang F, Liao L, Dong J. Front Endocrinol (Lausanne) 2023;14:1131044. - PMC - PubMed
    1. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Bahn Chair RS, Burch HB, Cooper DS, et al. Thyroid. 2011;21:593–646. - PubMed
    1. Resistance to thyroid hormones: a case-series study. Cannarella R, Musmeci M, Garofalo V, et al. Int J Mol Sci. 2022;23:11268. - PMC - PubMed
    1. The clinical significance of subclinical thyroid dysfunction. Biondi B, Cooper DS. Endocr Rev. 2008;29:76–131. - PubMed

Publication types

LinkOut - more resources